Duloxetine
- Product NDC
- 70518-0343
- 11-digit product format
- 705180343
- Labeler code
- 70518
- Product ID
- 70518-0343_e157b4cf-eeb1-c515-e053-2a95a90aa260
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DULOXETINE HYDROCHLORIDE
- Dosage form
- CAPSULE, DELAYED RELEASE PELLETS
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA203088
- Marketing category
- ANDA
- Marketing start
- 2017-03-20
- Marketing end
- 0000-00-00
- Substance
- DULOXETINE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0343-0 | 70518034300 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BLISTER PACK (70518-0343-0) | 2017-03-20 | 0000-00-00 | No | No | Current |
| 70518-0343-1 | 70518034301 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (70518-0343-1) | 2017-04-03 | 0000-00-00 | No | No | Current |